ShortageWatch RxUS drug shortage tracker, built on FDA data

โ† All shortages

Epinephrine Bitartrate, Lidocaine Hydrochloride Injection shortage

Current  22 presentations ยท 2 manufacturers ยท first FDA posting 2012-02-22 ยท last update 2026-10-15

Manufacturers: Fresenius Kabi USA, LLC, Hospira, Inc., a Pfizer Company

Stated reasons (per FDA): Demand increase for the drug; Other

๐Ÿ“ฌ Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)Fresenius Kabi USA, LLCCurrent
Unavailable
Demand increase for the drugNext release October 2026. Check wholesalers for inventory.Posted 10/14/2016
Updated 10/15/2026
Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17)Fresenius Kabi USA, LLCCurrent
Unavailable
Demand increase for the drugNext release November 2026. Check wholesalers for inventory.Posted 10/14/2016
Updated 10/15/2026
Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27)Fresenius Kabi USA, LLCCurrent
Available
โ€”Check wholesalers for inventoryPosted 10/14/2016
Updated 10/15/2026
Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57)Fresenius Kabi USA, LLCCurrent
Available
โ€”Check wholesalers for inventoryPosted 10/14/2016
Updated 10/15/2026
Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27)Fresenius Kabi USA, LLCCurrent
Available
โ€”Check wholesalers for inventoryPosted 10/14/2016
Updated 10/15/2026
Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57)Fresenius Kabi USA, LLCCurrent
Available
โ€”Check wholesalers for inventoryPosted 10/14/2016
Updated 10/15/2026
Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17)Fresenius Kabi USA, LLCCurrent
Available
โ€”Check wholesalers for inventoryPosted 10/14/2016
Updated 10/15/2026
Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37)Fresenius Kabi USA, LLCCurrent
Available
โ€”Check wholesalers for inventoryPosted 10/14/2016
Updated 10/15/2026
Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17)Fresenius Kabi USA, LLCCurrent
Available
โ€”Check wholesalers for inventoryPosted 10/14/2016
Updated 10/15/2026
Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37)Fresenius Kabi USA, LLCCurrent
Available
โ€”Check wholesalers for inventoryPosted 10/14/2016
Updated 10/15/2026
Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17)Fresenius Kabi USA, LLCCurrent
Available
โ€”Check wholesalers for inventoryPosted 10/14/2016
Updated 10/15/2026
Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27)Fresenius Kabi USA, LLCCurrent
Unavailable
OtherNext release October 2026. Check wholesalers for inventory.Posted 10/14/2016
Updated 10/15/2026
Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC 0409-1209-01)Hospira, Inc., a Pfizer CompanyCurrent
Unavailable
OtherNext Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayPosted 02/22/2012
Updated 10/08/2026
Lidocaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01)Hospira, Inc., a Pfizer CompanyCurrent
Unavailable
OtherNext Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayPosted 02/22/2012
Updated 10/08/2026
Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01)Hospira, Inc., a Pfizer CompanyCurrent
Unavailable
OtherNext Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayPosted 02/22/2012
Updated 10/08/2026
Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)Hospira, Inc., a Pfizer CompanyCurrent
Unavailable
OtherNext Delivery: January 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing DelayPosted 02/22/2012
Updated 10/08/2026
Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03)Hospira, Inc., a Pfizer CompanyCurrent
Limited Availability
OtherLimited Supply Available. Next Delivery: May 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing DelayPosted 02/22/2012
Updated 10/08/2026
Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01)Hospira, Inc., a Pfizer CompanyCurrent
Limited Availability
OtherLimited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayPosted 02/22/2012
Updated 10/08/2026
Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01)Hospira, Inc., a Pfizer CompanyCurrent
Unavailable
OtherNext Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing DelayPosted 02/22/2012
Updated 10/08/2026
Lidocaine Hydrochloride and Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC 0409-3182-02)Hospira, Inc., a Pfizer CompanyCurrent
Limited Availability
OtherLimited Supply Available. Next Delivery: May 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing DelayPosted 02/22/2012
Updated 10/08/2026
Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03)Hospira, Inc., a Pfizer CompanyCurrent
Limited Availability
OtherLimited Supply Available. Next Delivery: May 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing DelayPosted 02/22/2012
Updated 10/08/2026
Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01)Hospira, Inc., a Pfizer CompanyCurrent
Limited Availability
OtherLimited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayPosted 02/22/2012
Updated 10/08/2026

Source: FDA Drug Shortages Database ยท raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)